ESA Grand Rounds Webinar October 2020
Date: 26/10/2020
Venue: via Redback Connect, VIC, 3000
Provider: Eye Surgery Associates VIC
Contact: Megan Morris, [E] mmorris@eyesurgery.com.au, [P] 03 9416 0695
Learning Objectives
- Light on the Horizon: To review how evidence from randomised controlled trials supports the use of two less invasive treatment options, selective laser trabeculoplasty and a microstent.
- From drops to drug delivery: To understand the challenges posed by long-term medical therapy for both patients with glaucoma and practitioners and to provide an overview of sustained-delivery systems for continuous IOP-lowering.
- IOL selection in glaucoma patients: How to optimise visual outcomes after cataract surgery in patients with glaucoma.
- To be able to identify patients at risk for cystoid macular oedema after cataract surgery
- To be aware of the pathophysiology of macular oedema following cataract surgery
- To be familiar with some of the treatment options available for management of cystoid macular oedema after cataract surgery
Max points awarded: 3.00
Session Information
| Name |
|---|
| Latest treatments and advanced technologies in glaucoma |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |
| Name |
|---|
| Cystoid macular oedema after cataract surgery – are we missing the mark? |
| Activity Type |
| Face to Face without Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 1.50 |